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Ganoderma lucidum beta 1,3/1,6 glucan as
an immunomodulator in inflammation
induced by a high-cholesterol diet
Yu-Sheng Wu1†, Shu-Ying Ho1†, Fan-Hua Nan2 and Shiu-Nan Chen1*
Abstract
Background: Binding of beta 1,3/1,6 glucan of Ganoderma lucidum (G. lucidum) with the receptor results in a series
of signal transfers (signalling cascades), which activates the transcription factors for regulating inflammation. Excess
cholesterol intake leads to an increase in the distance between fat cells and capillaries, which may cause hypoxia in
the fat tissue of obese mice. This hypoxia induces the death of fat cells, resulting in the inflammation of adipose
tissue or an increase in the inflammatory gene expression associated with obesity.
Methods: The current study examined the immunomodulation effect of G. lucidum beta 1,3/1,6 glucan according
to immunoglobulin, poly-Ig receptor expression, Nature Killer cell (NK cell) activity, lymphocytes proliferation and
cytokines expression.
Results: Our present study shows that feeding G. lucidum beta 1,3/1,6 glucan to mice induces IgA or IgG expression in
the serum and small intestine washing fluid and enhances poly-Ig receptor expression in the small intestine moreover,
the observation of the IL-2 and Nature killer cell activity were exchanged.
Conclusions: The effect of a high-cholesterol diet in the inflammatory response was observed in heart, liver,
kidney, spleen, and colon tissues through histopathological evaluations. The presented evidence demonstrates
that the inflammation response in the high-cholesterol diet group was much higher than in the other groups
and the beta 1,3/1,6 glucan reduces inflammation in obese mice fed a high-cholesterol diet.
Background
Previous studies have shown that dietary cholesterol
affects the physiological performance of cells. The
literature indicates that in patients with high choles-
terol, endothelial cells, macrophages, and smooth
muscle cell membranes have increased cholesterol
content and undergo alteration in the membrane
composition, which affects cell functions such as
antigen-presenting capability and the interaction of
monocytes and endothelial cells [1, 2]. Ganoderma
lucidum is a medicinal mushroom which has been
widely used in the China and Japan for hundreds of
years for the immunomodulating, anti-inflammation and
anti-tumor effects. Many biological available substances,
in particular polysaccharides, with immunity enhance-
ment effects have been isolated from the extract of G. luci-
dum [3]. Previous, it has found that the fruiting body
extracts from Lentinus edodes, Trametes versicolor,
Ganoderma tsugae, Flammulina velutiper, Gano-
derma lucidum and Tricholoma matsutake demon-
strated significant anti-tumor activities towards
transplanted tumor cells of Sarcoma 180 [4, 5]. In pre-
vious studies, Autrodia comphorata-derived beta-glucan
has demonstrated inhibitory effects on tumor growth for
Sarcoma 37, Sarcoma 180, Erlich ascites sarcoma, Yoshida
sarcoma and Lewis lung carcinoma-1 (LLC1) transplanted
tumor growth [6].
Excessive intake of high-cholesterol foods leads to
chronic inflammation, and altered expression of in-
flammatory genes and proteins including cytokines,
chemokines, complement proteins, and adipokines
has been observed in most adipose tissue [7]. Patients
with a high body mass index usually present with
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higher concentrations of many adipokines, type 2 dia-
betes, and atherosclerosis [8]. Researchers conducting
systematic observations have demonstrated that the
macrophages from peripheral tissue penetrate human
and mouse adipose tissue to release inflammatory
substances, including TNF-α and IL-6. In addition, a
necrotic response of numerous fat cells was observed,
and pathologic findings suggested that adipose tissue
macrophages surrounded these necrotic cells [9, 10].
Previous research has indicated that the excessive
intake of fat leads to an increased distance between
fat cells and capillaries, and this may cause hypoxia
in the fat tissues of obese mice. This hypoxia induces
the death of fat cells, which results in the inflamma-
tion of adipose tissue or inflammatory gene expres-
sion associated with obesity known as ‘endoplasmic
reticulum stress’ [11, 12].
The intestinal mucosal immune response is
mounted by the mesenteric lymph nodes, and anti-
gens from gut-associated lymphoid tissue activate the
antigen-presenting system and enhance the inflamma-
tory response. Evidence indicates that inflammation
contributes to systemic metabolic dysfunction, which
is associated with inflammation disorders [13]. A
study showed that cytokines and pathogen-associated
molecular patterns (PAMPs) costimulate cell-surface
receptors including Toll-like receptors (TLRs) to initi-
ate intracellular signalling leading to the activation of
NF-κB. NF-κB activation was proposed to induce tar-
get gene expression to promote cellular proliferation
and activate the immune response [14].
Research has illustrated that β-glucans are PAMP mole-
cules that are recognised by pattern-recognition receptors,
such as TLRs and NOD-like receptors, and activate tran-
scription of proinflammatory genes [15]. Moreover, they
exhibit immune stimulatory activity and enhance wound
healing, particularly by increasing macrophage infiltration
to injury sites and stimulating tissue regeneration [16, 17].
The present research was performed in two parts; in
the first part, mice were administered mushroom beta-
glucan (MBG) to detect immunoglobulin (Ig) A and G
expression in the intestine and serum. Altered poly-Ig
receptor gene expression in the intestinal tissue was also
detected. By detecting Ig and poly-Ig receptor gene
expression, we explored the immunomodulation func-
tion of Ganoderma lucidum beta 1,3/1,6 glucan. In the
second part, we examined the regulation of the inflam-
matory response by G. lucidum beta 1,3/1,6 glucan
through histopathological evaluation.
Methods
All study procedures were performed in accordance with
the protocol approved by the National Taiwan University
Animal and Use Committee. Six-week-old male C57BL/
6 J mice (N = 6, purchased from Laboratory Animal Center,
National Taiwan University College of Medicine) were used
for this study, and they were housed in the Animal Housing
Facility of National Taiwan University, College of Life
Science in polycarbonate cages with paddy husk bedding in
the animal room. The room temperature and relative
humidity were maintained at 21 ± 2 °C and 55% ± 20%,
respectively, with a 12-h light/dark cycle.
Ganoderma lucidum beta 1,3/1,6 glucan
Our previous study examined the safety of MBG
[18], and in the present study, the mycelia of G.
lucidum were subcultured and maintained in sterile
yeast mould agar (0.02%) to produce MBG. The
manufacturing process was initiated by preparing a
culture medium containing glucose, lactose, galact-
ose, sucrose, mannose, and yeast extract. The myce-
lia of G. lucidum were then introduced into the
sterile medium and cultured using a shaker incuba-
tor at temperatures ranging from 27 °C to 32 °C for
3–5 weeks to achieve full polymerisation of MBG in
the culture system. Subsequently, MBG from the
cultured mycelia was homogenised and disrupted
using a high-speed homogeniser and ultrasonic vi-
bration. The MBG solution was then filtered and
concentrated using a ceramic membrane to remove
most of the residual small molecules in the solution.
The concentrated MBG was dried through lyophilisa-
tion and then grinded into a powdered form. The
sample contained approximately 95% carbohydrate,
1% fat, 1% protein, 2% ash, and 0.8% water. Using
Megazyme (Ireland) mushroom and the Yeast Beta-
Glucan Kit, we found that the crude extract con-
tained approximately 60–65% MBG. The molecular
weight of MBG was analysed through high-pressure
liquid chromatography (HPLC) by using the Shodex
sugar KS series containing KS-G, KS-804, and KS-
805 columns and detected using a RI 2000 detector.
The molecular weight was determined by referring
to the standard curve by using standard molecules
including STDP-800 (molecular weight 8 × 105),
STDP-400 (molecular weight 4 × 105), STDP-200
(molecular weight 2 × 105), STDP-100 (molecular
weight 1 × 105), and STDP-20 (molecular weight 2 ×
104). The glycosyl linkage of MBG was also analysed.
The sample was premethylated, depolymerised, re-
duced, and acetylated. The resultant partially methyl-
ated alditol acetates were then analysed through gas
chromatography-mass spectrometry (GC–MS), ac-
cording to the procedures described by York et al.
and Ciucanu et al. [19, 20].
The results of HPLC showed that the MBG powder
contained high-molecular-weight particles that ranged
from 9.6 to 298 kDa, and the results of GC-MS showed
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that the MBG powder contained 2-; 4-; and 6-linked
galactopyranosyl residues and 3-; 4; 3,4-; 2,4-; 4,6-; and
3,4,6-linked glucopyranosyl residues.
Immunmodulation of the G. lucidum beta 1,3/1,6-glucan
Proliferation of spleen lymphocytes
The spleen cell proliferation was examined using 3-
(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium
bromide MTT assay to select the in vitro appropriate
concentration of hydrogen peroxide functional role
in the macrophage18-20. At the end of incubation,
the cultured medium was removed and loading of
10 μl (5 mg/mL) MTT (SIGMA) into the plate and
incubated at 27 °C for 4 h. Thereafter, 200 μL of
dimethylsulfoxide (DMSO) was added to dissolve the
formazan measured by microplate Spectrophotometer
(μQunat, BioTek) at 590 nm.
The formula of Stimulation Ratio: (O.D. 590 in treat-
ment/O.D. 590 in control)
NK cell-mediated cytotoxicity in mice
Mice were euthanized and the monocytes from the spleen
were extracted for measurements of cytotoxicity. During
the extraction procedure, spleens were removed and shred-
ded with forceps, followed by separating the monocytes
with centrifugation using Histopaque. The isolated mono-
cytes were used as the effector cells after being washed
twice with PBS buffer and had the cell density adjusted to
1 × 106/mL in RPMI 1640 medium. YAC-1 cells, intended
to be used as the target cells, were collected by centrifuga-
tion and had the cell density adjusted to 1 × 106/mL. The
cells were then stained with DiOC-18 at 37 °C, 5% CO2 for
20 min, followed by a PBS rinse, and suspended to 1 × 106/
mL in RPMI 1640 medium. For the assay of NK cell-
mediated cytotoxicity, the effector and target cells were
mixed in ratios of 10 : 1 followed by adding the propidium
iodide (PI) staining solution to each mixture. Finally, the
cell mixtures were incubated at 37 °C, 5% CO2 for 2 h, and
analyzed with flow cytometer. Lysed (PI+ and DiOC-18+)
and viable (DiOC-18+ and PI−) YAC-1 cells were identified
by their dual- or single-positive staining. Assessment of the
NK cell-mediated cytotoxicity was defined by the percent-
age increase in cytotoxicity relative to the baseline level set
by the control group (100%).
Cytokines analysis
The IL-2 cytokines concentration of the blood was ana-
lysis by the ELISA method using the IL-2 ELISA Kit,
Mouse (Thermo Fisher Scientific).
Immunomodulation of inflammation
For examining G. lucidum beta 1,3/1,6-glucan as an
immunomodulator in the mouse inflammatory response,
the experimental group was divided into Group 1,
‘Control’, with oral feeding of twice-distilled water;
Group 2, ‘Glucan’, with oral feeding of G. lucidum beta-
glucan; and Group 3, ‘MIX’, with oral feeding of 200 μL
of 2 × 109 CFU/mL inactive Micrococcus lysodeikticus
and 100 μL of 8 mg/mLG. lucidum beta-glucan.
Inactive micrococcus lysodeikticus (M. lysodeikticus)
M. lysodeikticus was cultured in brain heart infusion
agar (Sigma) for 16 h and then washed with PBS. The
M. lysodeikticus solution was dispensed into a 50-mL
centrifuge tube with 10% formalin solution for 1 h and
centrifuged at 1000 × g for 15 min to remove the super-
natant. The centrifuged bacterial pellet was dissolved in
10 mL of PBS and centrifuged at 1000 × g for 15 min to
completely remove the formalin.
Small intestine washing fluid
The small intestine was removed and 20 mL of PBS
was irrigated through the intestinal lumen to obtain a
small intestine washing fluid (SIWF) sample. The
SIWF samples were centrifuged at 3000 rpm for
10 min, and the supernatant was collected and stored
for analysis 17.
Serum
Blood was collected from the heart and stored at 4 °C
for the serum sample.
Enzyme-linked immunosorbent assay
The concentrations of IgA and IgG were measured in
SIWF and serum through ELISA (ICL, USA). In brief,
separate 96-well plates were coated with the anti-mouse T
IgA or IgG, 100 uL of SIWF and serum or a standard
(ICL, USA) was added, and the plates were incubated at
room temperature. The plates were washed five times,
and a secondary antibody was added and incubated at
room temperature for 1 h. After incubation, the plates
were washed seven times, a substrate solution was added,
and the plates were incubated in the dark. The reaction
was stopped by a stop solution, and the absorbance was
read using a microplate reader.
Real-time polymerase chain reaction
RT-qPCR was used to analyse the gene expression of
poly-Ig receptor in the intestine, with β-actin used as the
reference gene. The experiments were conducted by
following the protocol published for SYBR Green Super-
mix Kits (Bio-Rad) and using Bio-Rad CFX384 touch
RT-PCR for analysis (Table 1).
Histopathological evaluations in mice fed a high-
cholesterol diet
For examining G. lucidum beta-glucan as an immuno-
modulator in the mouse inflammatory response induced
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by a high-cholesterol diet, the experimental group was
divided into Group 1,’Control’, with oral feeding of twice-
distilled water; Group 2, ‘Glucan’, with oral feeding of G.
lucidum beta-glucan; Group 3, ‘Cholesterol’, with a diet of
2% cholesterol with purified sodium cholate; and Group 4,
‘Glucan/Cholesterol’, with a diet of 2% cholesterol with
purified sodium cholate and 100 uL of 8 mg/mL MBG, as
presented in Table 2. The feed content (No. 47922291,
TestDiet, USA) is presented in Table 3.
Histopathological evaluation of tissues
The heart, liver, spleen, colon, and kidney were removed
and fixed with neutralised and buffered formalin. Tissue
sections were stained with Giemsa stain and observed
using light microscopy. The eosinophilic granulocytes
were stained light red, and the basophils and neutrophils
were stained purple and blue, respectively. The Nile blue
stain was used for staining lipids, and lipofuscin was
stained blue.
Statistical analysis The experimental data of each treat-
ment group were divided by those of control group.
Tukey’s honestly significant difference test and one-way
ANOVA were used to analyse the statistical significance
of differences between the treatment and control groups.
A p value less than 0.05 was considered statistically sig-
nificant. The results were presented as means ± SEM.
Results
Immunomodulation of the ganoderma lucidum beta
1,3/1,6 glucan
The NK cell-mediated cytotoxicity from healthy mice
treated with Ganoderma lucidum beta 1,3/1,6 glucan was
recorded. Results indicated that the cytotoxicity level
increased significantly after treated with the Ganoderma
lucidum beta 1,3/1,6 glucan, and with the level maintained
through the days observation (Fig. 1a and b). In the serum
cytokines, the experiment presented with a significant
increasing trend through the 3rd to 17th days observation
compared to the control (p <0.05), in the 20th to the 27th
day observation, it was not with significant alteration
(Fig. 1c). It was also recorded the spleen lymphocyte
proliferation, in the research, it was with a little increase
after treated with the Ganoderma lucidum beta 1,3/1,6
glucan (Fig. 1d).
Immunoglobulin expression in small intestine washing
fluid
IgA was the most abundant in the SIWF, with the average
amount in the control SIWF being 412.23 ± 3.08 ng/mL.
On the first day, the IgA concentration in the Glucan
group was 715.21 ± 94.01 ng/mL higher than that in the
Control and MIX (565.82 ± 120.22 ng/mL) groups. On the
second day, there was no significant difference between
the groups (p > 0.05), and the value in the Glucan and
MIX groups was 514.60 ± 160.66 ng/mL and 445.97 ±
80.79 ng/mL, respectively. On the fourth day, IgA was at a
concentration of 633.27 ± 178.99 ng/mL in the Glucan
group and 494.29 ± 50.21 ng/mL in the MIX group, and
there was no significant difference between the groups
(p > 0.05). On the seventh day, the concentration of IgA
was 609.17 ± 62.57 ng/mL in the Glucan group and
548.70 ± 53.51 ng/mL in the MIX group, and there was no
significant difference between the groups. The average
concentration of IgG produced in the SIWF was 10.15 ±
1.24 ng/mL. On the first day, the concentration of IgG
was 11.69 ± 5.21 ng/mL in the Glucan group and
10.38 ± 3.03 ng/mL in the MIX group. On the second
day, the concentration of IgG was 13.19 ± 5.12 ng/mL
in the Glucan group and 13.63 ± 1.40 ng/mL in the
Table 2 Groups and Their Respective Treatments
Day Feeding for 20 days Day 21
(sacrifice)Group
Control (con) twice-distilled water ×
Glucan (Glu) 100 ul of 8 mg/ml ×
Cholesterol
(Cho)






2% cholesterol with sodium cholate
purified Diet and 100 ul of 8 mg/ml
mushroom beta glucan
×
Table 1 Primer Sequences





Poly-Ig receptor F: AGGAGGTGAGTAGTATAGAAG NM_011082.3
R: GGAAGTTGATGAGGTTGG
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MIX group. There was no significant difference be-
tween the groups (p > 0.05). On the fourth day, the
concentration of IgG was 28.28 ± 11.24 ng/mL in the
Glucan group, which was significantly higher than
that in the MIX group (12.47 ± 3.14 ng/mL) (p < 0.05).
On the seventh day, there was no significant differ-
ence between the groups, as illustrated in Fig. 2.
Immunoglobulin expression in serum
The average amount of IgA in the serum was 29.24 ±
2.29 μg/mL. On the first day, the concentration of IgA
was 32.57 ± 3.64 μg/mL in the Glucan group and
36.60 ± 1.05 μg/mL in the MIX group, which were
higher than that in the Control group (p < 0.05). On
the second day, the concentration was 45.60 ± 7.87 μg/
mL in the MIX group, which was higher than that in
the Glucan group (32.47 ± 2.91 μg/mL) (p < 0.05). On
the fourth day, the production of IgA was 36.30 ±
2.99 μg/mL in the MIX group, which was higher than
that in the Glucan (34.03 ± 3.60 μg/mL) and Control
groups (p < 0.05). On the seventh day, there was no
significant difference between the groups (p > 0.05).
The average production of IgG in the serum was
428.16 ± 22.25 μg/mL. On the first day, the concentra-
tion was 453.50 ± 36.37 μg/mL in the Glucan group
and 462.78 ± 55.00 μg/mL in the MIX group, which
were higher than that in the Control group, and there
was no significant difference between the groups (p >
0.05). On the second day, the concentration was
491.50 ± 5.49 μg/mL in the MIX group and 466.95 ±
17.30 μg/mL in the Glucan group. On the fourth day,
the concentration was 666.95 ± 109.77 μg/mL in the
MIX group, which was lower than that in the Glucan
(1270.93 ± 211.01 μg/mL) and Control groups (p <
0.05). On the seventh day, the concentration in the MIX
group was 794.72 ± 185.19 μg/mL, which was significantly
higher than that in the Glucan group (439.85 ± 92.41 μg/




Fig. 1 a Flow Cytometric profiles of NK Cell activity by FlowMax software. DiOC18+/PI+ defined as dead YAC-1, were represented as signals
detected in the upper right-hand quadrant. b Effect of feeding with various concentration Ganoderma lucidum beta 1,3/1,6 glucan on the activity
of NK cells. Values sharing a common superscript are significantly different (p < 0.05). c Concentration of IL-2 in mouse serum. Values sharing a
common superscript are significantly different (p < 0.05). d Observation of spleen lymphocytes proliferation after Con-A or LPS stimulation
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Fig. 3 Immunoglobulin A and G production in the serum on different days. Group 1, ‘Control’: oral feeding with twice-distilled water; Group 2, ‘Glucan’:
oral feeding with Ganoderma lucidum beta-glucan; Group 3, ‘MIX’: oral feeding with 200 μL of 2 × 109 CFU/mL inactive Micrococcus lysodeikticus and
100 μL of 8 mg/mL G. lucidum beta-glucan
Fig. 2 Production of immunoglobulin A and G in small intestine washing fluid on different days. Group 1, ‘Control’: oral feeding with twice-distilled water;
Group 2, ‘Glucan’: oral feeding with Ganoderma lucidum beta-glucan; Group 3, ‘MIX’: oral feeding with 200 μL of 2 × 109 CFU/mL inactive Micrococcus
lysodeikticus and 100 μL of 8 mg/mL G. lucidum beta-glucan
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Poly-Ig receptor relative gene expression in the intestine
In this research, the average poly-Ig receptor relative
gene expression in the Control group was 0.26 ± 0.004.
On the first day, the relative gene expression in the Glu-
can group was 1.36 ± 0.14, which was significantly higher
than that in the MIX group, 0.70 ± 0.390 (p < 0.05). On
the second day, the value was 1.80 ± 0.14 in the Glucan
group and 1.11 ± 0.27 in the MIX group. On the fourth
day, it was 4.13 ± 1.07 in the Glucan group and 2.98 ±
1.17 in the MIX group. The relative gene expression
levels on the second and fourth days for the Glucan
and MIX groups were both significantly higher than
that in the Control group (p < 0.05), but were not dif-
ferent from each other. On the seventh day, there was
no significant difference between the groups (p > 0.05),
as illustrated in Fig. 4.
Histopathological evaluation of tissues
The results illustrated in Fig. 5 indicate that the expression
of basophilic granulocytes (purple) and neutrophils (light
blue) was significantly higher in the Cholesterol group
than in the other groups. In the Glucan/Cholesterol
group, inflammatory cell expression in the heart tissue
was significantly reduced compared with that in the Chol-
esterol group according to Giemsa staining. In the kidney,
the expression of basophilic granulocytes (purple) and
neutrophils (light blue) was significantly increased in the
Cholesterol group. In the Glucan/Cholesterol group, a
significantly reduced number of inflammatory cells was
observed compared with that in the Cholesterol group.
The histopathological evaluation of the liver revealed
that the expression of eosinophilic granulocytes (red)
and neutrophils (light blue) was higher in the Choles-
terol group compared with the other groups. In the
Glucan/Cholesterol group, the image revealed a reduced
number of inflammatory cells compared with the
Cholesterol group according to Giemsa staining. The
Nile blue stain was used to observe lipid accumulation
in the tissue, and the accumulation of lipoid and
lipofuscin (blue) was increased in the Cholesterol group
compared with the other groups. In the Glucan/Choles-
terol group, the accumulation of lipoid and lipofuscin
was significantly reduced, as illustrated in Fig. 6. The
colon tissue appeared dark black in the Cholesterol
group. In addition, according to Giemsa and Nile blue
staining, the colon tissue appeared severely necrotic and
eroded in the Cholesterol group. In the Glucan/Choles-
terol group, the colon tissue was more complete com-
pared with that in the Cholesterol group. Under the
light microscope, the colon tissue showed accumulation
of inflammatory cells, lipoid, and lipofuscin, but exhib-
ited complete patterns, as illustrated in Fig. 7. The
spleen tissue after Giemsa staining showed an increased
number of eosinophilic and neutrophil granulocytes in
the Cholesterol group compared with the other groups,
and the number of inflammatory cells was reduced in
the Glucan/Cholesterol group, as illustrated in Fig. 8.
Discussion and conclusions
Mice fed a high-cholesterol diet were observed to realise
whether the diet induced a pathological response in the
liver. The results of this research indicated that the liver of
C57BL/6 J mice exhibited severe inflammatory characteris-
tics. In addition, the high-cholesterol diet increased expres-
sion of the transcription factor NF-κB relative to that in the
Control group and induced the infiltration of inflammatory
macrophages into the tissue in the short term. Moreover, a
previous study demonstrated that a decreased fat intake
may reduce very-low-density lipoprotein production in the
plasma and prevent the development of liver inflammation
and live foamy cells [21].
Mushroom beta 1,3–1,6 glucan is a complex, high-
molecular-weight polysaccharide that is present in the
cell wall of various mushrooms and has obvious im-
munomodulatory functions [22, 23]. Mushroom beta
1,3–1,6 glucan has a variety of effects in animals with
immunomodulatory functions such as raising the
phagocytic activity of macrophages and increasing the
number of natural killer cells to enhance the ability
to stimulate cytokines and thus activate the immune
system. Macrophages, dendritic cells, and other non-
immune cells comprise nonspecific pattern-
recognition receptors for complement receptor type 3
(CR3 receptor), which is a well-known beta-glucan re-
ceptor [24]. A study demonstrated that MBG combin-
ing with the CR3 receptor leads to a series of signal
transfers (signalling cascades), which activates the
transcription factors for regulating the inflammation
response, the antigen-presenting procedure, and major
histocompatibility complex performance [25].
A correlation study reported that feeding mice a high-
cholesterol diet led to a high number of eosinophils, an
Fig. 4 Poly-Ig Receptor relative gene expression in the intestine. Group
1, ‘Control’: oral feeding with twice-distilled water; Group 2, ‘Glucan’: oral
feeding with Ganoderma lucidum beta-glucan; Group 3, ‘MIX’: oral
feeding with 200 μL of 2 × 109 CFU/mL inactive Micrococcus lysodeikticus
and 100 μL of 8 mg/mLG. lucidum beta-glucan
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increase in IL-5, and high concentrations of PGE2 and
MCP-1 in the lung tissue. In an ex vivo experiment,
cultured lymphocytes released high concentrations of
IL-4 and IFN-γ; moreover, these inflammatory factors
were significantly and positively correlated with serum
cholesterol concentrations [26, 27]. Adding drinking
water with a cholesterol-lowering drug, pravastatin, sig-
nificantly reduced the infiltration of eosinophils and the
expression of IL-5, PGE2, and MCP-1 in lung lavage
fluid [27, 28].
Fig. 5 Histopathological evaluation of the heart and kidney using Giemsa stain. Group 1, ‘Control’: oral feeding with twice-distilled water; Group
2, ‘Glucan’: oral feeding with Ganoderma lucidum beta-glucan; Group 3, ‘Cholesterol’: a diet of 2% cholesterol with purified sodium cholate; Group
4, ‘Glucan/Cholesterol’: a diet of 2% cholesterol with purified sodium cholate and 100 μL of 8 mg/mL mushroom beta-glucan
Fig. 6 Histopathological evaluation of the liver using Giemsa and Nile blue stains. Group 1, ‘Control’: oral feeding with twice-distilled water; Group
2, ‘Glucan’: oral feeding with Ganoderma lucidum beta-glucan; Group 3, ‘Cholesterol’: a diet of 2% cholesterol with purified sodium cholate; Group
4, ‘Glucan/Cholesterol’: a diet of 2% cholesterol with purified sodium cholate and 100 μL of 8 mg/mL mushroom beta-glucan
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The effect of a high-cholesterol diet in the inflam-
matory response was observed in heart, liver, kidney,
spleen, and colon tissues through histopathological
evaluations. The presented evidence demonstrates that
the inflammation response in the high-cholesterol diet
group was much higher than that in the other groups,
particularly in the colon tissue, which exhibited ne-
crosis and erosion.
Treatment of Autrodia comphorata-beta-glucan has
been demonstrated to slow tumor growth and reduce
the rate of metastasis [29] and illustrated that cytotoxic
T-cells activity and tumor occurrence rate were ob-
served. Results also showed that daily oral with Grifola
frondosua-beta glucan is capable of enhancing the cyto-
toxic T-cells activity and decrease tumor occurrence rate
[30]. Additionally, they found that the addition of
Fig. 7 Histopathological evaluation of the colon using Giemsa and Nile blue stains. Group 1, ‘Control’: oral feeding with twice-distilled water;
Group 2, ‘Glucan’: oral feeding with Ganoderma lucidum beta-glucan; Group 3, ‘Cholesterol’: a diet of 2v cholesterol with purified sodium cholate;
Group 4, ‘Glucan/Cholesterol’: a diet of 2% cholesterol with purified sodium cholate and 100 μL of 8 mg/mL mushroom beta-glucan
Fig. 8 Histopathological evaluation of the spleen using Giemsa stain. Group 1, ‘Control’: oral feeding with twice-distilled water; Group 2, ‘Glucan’:
oral feeding with Ganoderma lucidum beta-glucan; Group 3, ‘Cholesterol’: a diet of 2% cholesterol with purified sodium cholate; Group 4, ‘Glucan/
Cholesterol’: a diet of 2% cholesterol with purified sodium cholate and 100 μL of 8 mg/mL mushroom beta-glucan
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conditioned medium with tumor cells into the progeni-
tor cells of dendritic cells can further inhibit maturation
of dendritic cells and lower the antigen presenting cap-
ability of the dendritic cells [31].
The immunotherapy is being developed with some
beneficial advantage of alternative medicine as immu-
nomodulation factors as mushroom beta glucan, anti-
microbial peptides and the triterpenoid that represent
a novel therapeutic approach for anti-inflammation as
immunotherapy be an alternative therapy applied in
the early phase of clinical therapy and immunomodu-
lation on the early phase of immune disease.
Although G. lucidum beta 1,3/1,6-glucan acts as an im-
munomodulator and reduces the inflammatory response,
the evidence does not directly support reduction in the
accumulation of cholesterol in the organs.
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